Alka Shrikhande

Varenicline:  An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

Jotham W. Coe, Paige R. Brooks, Michael G. Vetelino et al. · Journal of Medicinal Chemistry · 2005 · 933 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Inhibition of the striatum-enriched phosphodiesterase PDE10A: A novel approach to the treatment of psychosis

Judith A. Siuciak, Douglas S. Chapin, John F. Harms et al. · Neuropharmacology · 2006 · 274 citations

Medicine, Neuroscience, Pharmacology +12

Pre‐clinical properties of the α4β2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence

Hans Rollema, Alka Shrikhande, KM Ward et al. · British Journal of Pharmacology · 2010 · 166 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

<i>N</i>-terminal sequence of proteoglycan fragments isolated from medium of interleukin-1-treated articular-cartilage cultures. Putative site(s) of enzymic cleavage

Pat Loulakis, Alka Shrikhande, Gary L. Davis et al. · Biochemical Journal · 1992 · 132 citations · Full text

Life Sciences, Cell Biology, Immunology +14

Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect

Hans Rollema, Victor Guanowsky, Yann S. Mineur et al. · European Journal of Pharmacology · 2009 · 86 citations · Full text

Medicine, Pharmacology, Psychiatry +13